3rd gen glp 1 Lilly's triple-acting obesity drug hits goal in Phase 3 trial GLP-1 receptor agonists and next-generation

Wegovy users report an average weight loss of 15-22% of body weight in clinical trials, with some patients losing more than 50 pounds

It was inevitable

Denver residents can now access compounded semaglutide through PlexusDx, a precision health company offering personalized GLP-1 therapy without insurance requirements or membership fees

Expert guidance on forms, dosage, timing, and interactions to support your diabetes or weight management treatment safely and effectively.

Learn the best place to inject Ozempic and tips on how to administer safely and effectively at each injection site.

These usually improve after a few days or weeks as the body adjusts